… Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients
with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a …

… safety of biological therapies in patients with psoriasis and concomitant hepatitis B or C virus
… was limited by the retrospective nature of most of the included studies. Therefore, some …

… on case reports and small retrospective cohort studies. … in 14 psoriatic patients undergoing
therapy with ustekinumab. … -negative patients, a prospective multicenter study by Fukuda et …

… -severe plaque psoriasis in patients who are candidates for phototherapy or systemic therapy
(… Compared with placebo or etanercept, a tumor necrosis factor (TNF) inhibitor, it effectively …

… one prospective multicenter study showed that individuals with … ustekinumab at week
52 [Citation28]. The results implied that … hepatitis B virus (HBV) markers receiving anti-TNF-alpha …

… Hepatitis B virus and hepatitis C virus infections do not … multicenter study; in particular, liver
biochemistry, cholestasis … cirrhotic patients with severe psoriasis treated with ustekinumab. …

… other settings[19]. Apart from a couple of retrospective studies reporting HBVr among patients
… , 3 HBsAg negative/HBcAb positive) patients with psoriasis eligible for ustekinumab based …

… Brazilian multicenter study assessed data from 1,037 patients (… hepatitis B and C virus
reactivation in patients with psoriasis … The safety profile of ustekinumab in the treatment of patients …

… virus-specific CD8+ T cells and viral replication of hepatitis B … with psoriasis) showed that
TNF inhibitors and ustekinumab … multicenter retrospective cohort study including 60 patients …

… An Italian retrospective multicenter study collected data on … HBV infection patients with
psoriasis received ustekinumab. … No literature data on their use in the setting of HBV infection …